Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Part 1 of this study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VT7208 in healthy volunteers. Part 2 of this study will be an open-label, randomized study to characterize the effect of food on the pharmacokinetics of VT7208 in healthy volunteers. Part 3 of this study will evaluate the safety of VT7208 as monotherapy in patients with MS.
Epistemonikos ID: 6c72464baa5cb6f09c8250ad9ded03d9bd12d4a2
First added on: Jul 26, 2025